43rd ISICEM

P215

Mathanke Vivekanandan

Sepsis golden hour algorithm: impact on outcomes

P216

Peter Pickkers

Precision medicine in septic shock with enibarcimab ? biomarker guided definition of target population

P217

Fabian Bohländer

Modulation of NET release by plasma derived immunoglobulins: Trimodulin (polyvalent IgM, IgA, IgG solution) vs. standard IVIg

P218

Evangelos Giamarellos?Bourboulis

Probiotics as modifiers of the innate immune response in COVID-19 and ARDS: a case-control study

P219

Fiona MacGregor

Tocilizumab timing and COVID-19 mortality: a cohort study of early vs late administration

P220

Vladimir Pisarev

Hemoperfusion with efferon lps neo device reverts multiple organ failure, decreases IL-6 and tnf levels and systemic immune inflammation in children with sepsis

P221

Teresa Klaus

The international, prospective COSMOS registry on the use of CytoSorb® in critically ill patients: preliminary results after first 100 patients

P222

Yuki Kotani

Mortality comparison between positive single-center randomized trials and subsequent multicenter randomized trials in critically ill patients: a systematic review

P223

Stuthi Iyer

Cardiac dysfunction is common prior to sepsis hospitalization

P224

Filipe André Gonzalez

The effects of vasopressin in combination with norepinephrine in cardiac function